Cellebrite DI (CLBT) Market Capitalization (2020 - 2026)

Cellebrite DI has reported Market Capitalization for 7 years, with the latest figure at $3.6 billion in Q2 2026.

• On a quarterly basis, Market Capitalization fell 4.95% year-over-year to $3.6 billion in Q2 2026; TTM through Jun 2026 was $3.6 billion, a 4.95% decrease from a year earlier, with the FY2025 full-year figure at $4.5 billion, down 14.75% from the prior year.
• Market Capitalization was $3.6 billion for Q2 2026 at Cellebrite DI, up from $3.4 billion in the prior quarter.
• The five-year high for Market Capitalization was $5.3 billion in Q4 2024, with the low at $488.7 million in Q3 2022.
• Average Market Capitalization over 5 years is $2.6 billion, with a median of $2.4 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization plunged 57.67% in 2022, then jumped 204.76% in 2023.
• Over 5 years, Market Capitalization stood at $848.8 million in 2022, then jumped by 109.45% to $1.8 billion in 2023, then surged by 196.73% to $5.3 billion in 2024, then retreated by 14.75% to $4.5 billion in 2025, then fell by 19.02% to $3.6 billion in 2026.
• The last three Market Capitalization figures came in at $3.6 billion (Q2 2026), $3.4 billion (Q1 2026), and $4.5 billion (Q4 2025), per Business Quant data.